Welcome to HealthyDogPetCo Blog

top
Page
Menu
News

Sitemap xml

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. .
COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R. . JAMA. 2021 Sep 8. doi: 10.1001/jama.2021.15494. Online ahead of print. JAMA. 2021. PMID: 34495304 No abstract available. .
.
Impact of the Delta variant on vaccine efficacy and response strategies.
Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, Mao Q, Xu M, Liang Z. Bian L, et al. .
.

top
top
Page
Menu
News
top
Page
Menu
News
Home Print viewSitemap
 
top
Page
Menu
News